Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression data from nine pediatric glioblastoma tumor samples

ABSTRACT: Expression data of a small series of pediatric glioblastomas were used as a control in a comparison with ependymoma tumors

ORGANISM(S): Homo sapiens

PROVIDER: GSE134404 | GEO | 2019/08/06

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Gene expression data from nine pediatric glioblastoma tumor samples

Project description:Gene expression data from nine pediatric glioblastoma tumor samples

| PRJNA555058 | ENA

Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased tumor YB-1 expression

Project description:Our aim was to gain insight into the molecular pathways that distinguish pediatric- from adult-onset glioblastomas.

2010-01-22 | GSE20018 | GEO

Epigenetic Landscape of Pediatric Ependymoma Recurrence

Project description:Pediatric ependymoma has relatively low frequencies of DNA mutations, which suggest that epigenetics may drive tumors. However, the epigenetic mechanisms for recurrent ependymoma are still poorly understood. Here, we performed longitudinal and comprehensive DNA methylation and gene expression analysis for recurrent pediatric ependymoma tumors from 10 patients, total 46 DNA methylomes (including primary tumors and matched recurrent tumors; normal pediatric brain tissues and PDOX tumors). Both RELA and PFA tumors maintained the subtype DNA methylation signatures during repeated relapses. We further identified the potential DNA methylation predictors, drivers and boosters and their potential regulated genes for recurrent ependymoma tumors. Increased DNA methylation levels within H3K4me1 enriched regions indicates disturbed functions of LSD1 gene in recurrent ependymoma tumors. Combining novel LSD1 inhibitor SYC-836 with radiation (XRT) significantly prolonged animal survival times in PDOX models of recurrent PFA ependymoma. Our PDOX models provide a unique platform for preclinical testing drugs and development of new therapy for pediatric recurrent ependymoma.

2022-07-12 | GSE156619 | GEO

Gene expression data from Brazilian pediatric ependymoma samples.

Project description:Ependymoma (EPN) is the third most common central nervous system (CNS) tumor in childhood and, recently, has been classified in nine robust molecular subgroups (Pajtler et al., 2015). However, molecular and clinical features of pediatric EPNs from Brazilian cohorts remain unexplored. Herein, we aimed to analyze the gene expression profile among three different molecular subgroups: ST-EPN-RELA, ST-EPN-YAP1 and PF-EPN-A.

2023-03-03 | GSE181162 | GEO

Genomics and epigenetics: A study of ependymomas in pediatric patients

Project description:In this work the objective is identify chromosomal alterations in ependymoma in pediatric patients, we used CGH microarray were performed through the Agilent platform.

2016-03-15 | E-MTAB-3850 | biostudies-arrayexpress

SNP microarry analysis of primary and first recurrent pediatric ependymoma

Project description:We compared genomic characteristics of primary and first recurrent pediatric ependymoma to identify sub-group specific differences.

2016-09-11 | GSE50876 | GEO

Epigenetic Landscape of Pediatric Ependymoma Recurrence

Project description:Epigenetic Landscape of Pediatric Ependymoma Recurrence

| PRJNA658524 | ENA

CN133 hampers tumor growth in patient-derived pediatric ependymoma models

Project description:CN133 hampers tumor growth in patient-derived pediatric ependymoma models

| PRJNA578748 | ENA

Single-cell RNA-seq of pediatric ependymoma

Project description:Single-cell RNA-seq of pediatric ependymoma

| PRJNA593551 | ENA

Temporal and Clonal Progression in Pediatric Ependymoma

Project description:Temporal and Clonal Progression in Pediatric Ependymoma